DAVITA INC. Increase (Decrease) in Employee Related Liabilities
DAVITA INC. (DVA) reported Increase (Decrease) in Employee Related Liabilities of -$108.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-04
- DAVITA INC. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was -$19.98M, a 806.22% decline year-over-year.
- DAVITA INC. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$88.34M.
- DAVITA INC. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was -$43.32M.
- DAVITA INC. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $144.64M, a 3.65% decline year-over-year.
- DAVITA INC. increase (decrease) in employee related liabilities for fiscal 2025 was -$24.04M, a 263.70% decline from fiscal 2024.
- DAVITA INC. increase (decrease) in employee related liabilities for fiscal 2024 was $14.69M, a 73.87% decline from fiscal 2023.
- DAVITA INC. increase (decrease) in employee related liabilities for fiscal 2023 was $56.21M, a 62.75% increase from fiscal 2022.
- DAVITA INC. increase (decrease) in employee related liabilities for fiscal 2022 was $34.54M.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$108.32M 10-Q · filed 2026-08-04 | -$151.64M derived: sum of 3 quarters · filed 2026-08-04 | -$7.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$88.34M 10-Q · filed 2026-05-05 | -$131.66M derived: sum of 2 quarters · filed 2026-05-05 | $12.98M derived: sum of 3 quarters · filed 2026-05-05 | $15.81M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$43.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $101.32M derived: sum of 2 quarters · filed 2026-02-11 | $104.15M derived: sum of 3 quarters · filed 2026-08-04 | -$24.04M 10-K · filed 2026-02-11 |
| 2025-09-30 | $144.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $147.47M derived: sum of 2 quarters · filed 2026-08-04 | $19.28M 10-Q · filed 2025-10-29 | $6.65M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$125.36M 10-Q · filed 2026-08-04 | -$137.99M derived: sum of 3 quarters · filed 2026-08-04 | $12.14M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$128.19M 10-Q · filed 2026-05-05 | -$140.82M derived: sum of 2 quarters · filed 2026-05-05 | $9.31M derived: sum of 3 quarters · filed 2026-05-05 | $21.53M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$12.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $137.50M derived: sum of 2 quarters · filed 2026-02-11 | $149.73M derived: sum of 3 quarters · filed 2026-02-11 | $14.69M 10-K · filed 2026-02-11 |
| 2024-09-30 | $150.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $162.35M derived: sum of 2 quarters · filed 2025-10-29 | $27.31M 10-Q · filed 2025-10-29 | $18.24M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $12.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$122.82M 10-Q · filed 2025-08-05 | -$131.89M derived: sum of 3 quarters · filed 2026-02-11 | $2.19M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -$135.04M 10-Q · filed 2025-05-12 | -$144.11M derived: sum of 2 quarters · filed 2026-02-11 | -$10.03M derived: sum of 3 quarters · filed 2026-02-11 | -$4.69M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -$9.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $125.01M derived: sum of 2 quarters · filed 2026-02-11 | $130.35M derived: sum of 3 quarters · filed 2026-02-11 | $56.21M 10-K · filed 2026-02-11 |
| 2023-09-30 | $134.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $139.42M derived: sum of 2 quarters · filed 2024-10-29 | $65.28M 10-Q · filed 2024-10-29 | $64.32M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $5.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$68.80M 10-Q · filed 2024-08-06 | -$69.75M derived: sum of 3 quarters · filed 2025-02-13 | $68.25M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | -$74.14M 10-Q · filed 2024-05-02 | -$75.10M derived: sum of 2 quarters · filed 2025-02-13 | $62.91M derived: sum of 3 quarters · filed 2025-02-13 | $56.32M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | -$955.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $137.05M derived: sum of 2 quarters · filed 2025-02-13 | $130.46M derived: sum of 3 quarters · filed 2025-02-13 | $34.54M 10-K · filed 2025-02-13 |
| 2022-09-30 | $138.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $131.42M derived: sum of 2 quarters · filed 2023-11-07 | $35.49M 10-Q · filed 2023-11-07 | $25.95M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$6.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$102.51M 10-Q · filed 2023-08-03 | -$112.05M derived: sum of 3 quarters · filed 2024-02-14 | -$28.85M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | -$95.93M 10-Q · filed 2023-05-08 | -$105.47M derived: sum of 2 quarters · filed 2024-02-14 | -$22.26M derived: sum of 3 quarters · filed 2024-02-14 | $13.69M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | -$9.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $73.66M derived: sum of 2 quarters · filed 2024-02-14 | $109.61M derived: sum of 3 quarters · filed 2024-02-14 | -$16.72M 10-K · filed 2024-02-14 |
| 2021-09-30 | $83.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31 | $119.15M derived: sum of 2 quarters · filed 2022-10-31 | -$7.18M 10-Q · filed 2022-10-31 | -$15.98M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $35.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | -$90.38M 10-Q · filed 2022-08-01 | -$99.19M derived: sum of 3 quarters · filed 2023-02-22 | -$91.99M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | -$126.33M 10-Q · filed 2022-05-05 | -$135.14M derived: sum of 2 quarters · filed 2023-02-22 | -$127.94M derived: sum of 3 quarters · filed 2023-02-22 | -$50.83M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | -$8.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$1.61M derived: sum of 2 quarters · filed 2023-02-22 | $75.50M derived: sum of 3 quarters · filed 2023-02-22 | -$20.93M 10-K · filed 2023-02-22 |
| 2020-09-30 | $7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $84.30M derived: sum of 2 quarters · filed 2021-10-28 | -$12.12M 10-Q · filed 2021-10-28 | $31.11M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $77.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$19.32M 10-Q · filed 2021-08-03 | $23.91M derived: sum of 3 quarters · filed 2022-02-11 | $54.45M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | -$96.43M 10-Q · filed 2021-04-29 | -$53.20M derived: sum of 2 quarters · filed 2022-02-11 | -$22.65M derived: sum of 3 quarters · filed 2022-02-11 | $62.46M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $43.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $73.78M derived: sum of 2 quarters · filed 2022-02-11 | $158.89M derived: sum of 3 quarters · filed 2022-02-11 | -$14.70M 10-K · filed 2022-02-11 |
| 2019-09-30 | $30.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $115.65M derived: sum of 2 quarters · filed 2020-10-29 | -$57.93M 10-Q · filed 2020-10-29 | -$13.99M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $85.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$88.47M 10-Q · filed 2020-07-30 | -$44.53M derived: sum of 3 quarters · filed 2021-02-12 | -$28.13M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | -$173.58M 10-Q · filed 2020-05-05 | -$129.64M derived: sum of 2 quarters · filed 2021-02-12 | -$113.24M derived: sum of 3 quarters · filed 2021-02-12 | -$26.87M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $43.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $60.35M derived: sum of 2 quarters · filed 2021-02-12 | $146.72M derived: sum of 3 quarters · filed 2021-02-12 | $84.17M 10-K · filed 2021-02-12 |
| 2018-09-30 | $16.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $102.78M derived: sum of 2 quarters · filed 2019-11-07 | $40.23M 10-Q · filed 2019-11-07 | $22.05M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $86.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $23.82M 10-Q · filed 2019-08-02 | $5.64M derived: sum of 3 quarters · filed 2020-02-21 | $9.31M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | -$62.55M 10-Q · filed 2019-05-07 | -$80.73M derived: sum of 2 quarters · filed 2020-02-21 | -$77.06M derived: sum of 3 quarters · filed 2020-02-21 | -$77.96M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | -$18.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$14.51M derived: sum of 2 quarters · filed 2020-02-21 | -$15.41M derived: sum of 3 quarters · filed 2020-02-21 | -$78.24M 10-K · filed 2020-02-21 |
| 2017-09-30 | $3.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $2.76M derived: sum of 2 quarters · filed 2018-11-07 | -$60.06M 10-Q · filed 2018-11-07 | -$71.08M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | -$902.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$63.73M 10-Q · filed 2018-08-01 | -$74.74M derived: sum of 3 quarters · filed 2019-02-22 | -$36.55M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | -$62.83M 10-Q · filed 2018-05-03 | -$73.84M derived: sum of 2 quarters · filed 2019-02-22 | -$35.65M derived: sum of 3 quarters · filed 2019-02-22 | $38.36M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | -$11.02M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $27.17M derived: sum of 2 quarters · filed 2019-02-22 | $101.18M derived: sum of 3 quarters · filed 2019-02-22 | $68.27M 10-K · filed 2019-02-22 |
| 2016-09-30 | $38.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $112.20M derived: sum of 2 quarters · filed 2017-11-07 | $79.29M 10-Q · filed 2017-11-07 | $11.16M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | $74.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $41.10M 10-Q · filed 2017-08-01 | -$27.03M derived: sum of 3 quarters · filed 2018-02-23 | $122.36M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | -$32.91M 10-Q · filed 2017-05-02 | -$101.04M derived: sum of 2 quarters · filed 2018-02-23 | $48.36M derived: sum of 3 quarters · filed 2018-02-23 | -$8.60M derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | -$68.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $81.27M derived: sum of 2 quarters · filed 2018-02-23 | $24.31M derived: sum of 3 quarters · filed 2018-02-23 | $54.95M 10-K · filed 2018-02-23 |
| 2015-09-30 | $149.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $92.44M derived: sum of 2 quarters · filed 2016-11-02 | $123.08M 10-Q · filed 2016-11-02 | $72.77M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-06-30 | -$56.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$26.32M 10-Q · filed 2016-08-08 | -$76.63M derived: sum of 3 quarters · filed 2017-02-24 | $51.03M derived: sum of 4 quarters · filed 2017-02-24 |
| 2015-03-31 | $30.64M 10-Q · filed 2016-05-04 | -$19.67M derived: sum of 2 quarters · filed 2017-02-24 | $107.99M derived: sum of 3 quarters · filed 2017-02-24 | $104.33M derived: sum of 4 quarters · filed 2017-02-24 |
| 2014-12-31 | -$50.31M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $77.35M derived: sum of 2 quarters · filed 2017-02-24 | $73.69M derived: sum of 3 quarters · filed 2017-02-24 | $97.26M 10-K · filed 2017-02-24 |
| 2014-09-30 | $127.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $124.00M derived: sum of 2 quarters · filed 2015-11-05 | $147.57M 10-Q · filed 2015-11-05 | $71.06M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | -$3.66M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-05 | $19.91M 10-Q · filed 2015-08-05 | -$56.60M derived: sum of 3 quarters · filed 2016-02-26 | $72.56M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $23.57M 10-Q/A · filed 2015-05-08 | -$52.94M derived: sum of 2 quarters · filed 2016-02-26 | $76.22M derived: sum of 3 quarters · filed 2016-02-26 | $65.73M derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | -$76.51M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $52.65M derived: sum of 2 quarters · filed 2016-02-26 | $42.16M derived: sum of 3 quarters · filed 2016-02-26 | $38.37M 10-K · filed 2016-02-26 |
| 2013-09-30 | $129.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $118.67M derived: sum of 2 quarters · filed 2014-11-06 | $114.88M 10-Q · filed 2014-11-06 | $20.25M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | -$10.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$14.28M 10-Q · filed 2014-08-01 | -$108.90M derived: sum of 3 quarters · filed 2015-02-26 | -$19.01M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | -$3.79M 10-Q · filed 2014-05-02 | -$98.42M derived: sum of 2 quarters · filed 2015-02-26 | -$8.52M derived: sum of 3 quarters · filed 2015-02-26 | -$26.94M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | -$94.63M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$4.73M derived: sum of 2 quarters · filed 2015-02-26 | -$23.15M derived: sum of 3 quarters · filed 2015-02-26 | $18.48M 10-K · filed 2015-02-26 |
| 2012-09-30 | $89.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $71.48M derived: sum of 2 quarters · filed 2013-11-06 | $113.10M 10-Q · filed 2013-11-06 | $68.54M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | -$18.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $23.21M 10-Q · filed 2013-08-07 | -$21.35M derived: sum of 3 quarters · filed 2014-02-21 | $32.27M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $41.62M 10-Q · filed 2013-05-09 | -$2.93M derived: sum of 2 quarters · filed 2014-02-21 | $50.69M derived: sum of 3 quarters · filed 2014-02-21 | $87.16M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | -$44.56M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $9.07M derived: sum of 2 quarters · filed 2014-02-21 | $45.53M derived: sum of 3 quarters · filed 2014-02-21 | $77.07M 10-K · filed 2014-02-21 |
| 2011-09-30 | $53.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $90.09M derived: sum of 2 quarters · filed 2012-10-31 | $121.63M 10-Q · filed 2012-10-31 | $88.72M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $36.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $68.01M 10-Q · filed 2012-08-03 | $35.09M derived: sum of 3 quarters · filed 2013-03-01 | $42.10M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $31.54M 10-Q · filed 2012-05-02 | -$1.37M derived: sum of 2 quarters · filed 2013-03-01 | $5.63M derived: sum of 3 quarters · filed 2013-03-01 | $53.78M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | -$32.91M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$25.91M derived: sum of 2 quarters · filed 2013-03-01 | $22.24M derived: sum of 3 quarters · filed 2013-03-01 | $39.59M 10-K · filed 2013-03-01 |
| 2010-09-30 | $7.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $55.15M derived: sum of 2 quarters · filed 2011-11-04 | $72.50M 10-Q · filed 2011-11-04 | $42.63M derived: sum of 4 quarters · filed 2012-07-06 |
| 2010-06-30 | $48.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $65.50M 10-Q · filed 2011-08-04 | $35.62M derived: sum of 3 quarters · filed 2012-07-06 | $19.28M derived: sum of 4 quarters · filed 2012-07-06 |
| 2010-03-31 | $17.35M 10-Q · filed 2011-05-06 | -$12.52M derived: sum of 2 quarters · filed 2012-07-06 | -$28.87M derived: sum of 3 quarters · filed 2012-07-06 | $29.61M derived: sum of 4 quarters · filed 2012-07-06 |
| 2009-12-31 | -$29.87M derived: 8-K 12 month − 10-Q 9 month · filed 2012-07-06 | -$46.22M derived: sum of 2 quarters · filed 2012-07-06 | $12.27M derived: sum of 3 quarters · filed 2012-07-06 | -$9.14M 8-K · filed 2012-07-06 |
| 2009-09-30 | -$16.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $42.14M derived: sum of 2 quarters · filed 2010-11-05 | $20.73M 10-Q · filed 2010-11-05 | $883.00K derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | $58.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05 | $37.08M 10-Q · filed 2010-08-05 | $17.23M derived: sum of 3 quarters · filed 2011-02-25 | $1.38M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | -$21.40M 10-Q · filed 2010-05-03 | -$41.25M derived: sum of 2 quarters · filed 2011-02-25 | -$57.10M derived: sum of 3 quarters · filed 2011-02-25 | |
| 2008-12-31 | -$19.85M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | -$35.69M derived: sum of 2 quarters · filed 2011-02-25 | -$31.60M 10-K · filed 2011-02-25 | |
| 2008-09-30 | -$15.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | -$11.75M 10-Q · filed 2009-11-05 | ||
| 2008-06-30 | $4.09M 10-Q · filed 2009-08-07 | |||
| 2007-12-31 | $9.69M 10-K · filed 2010-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |